Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation - sprookjes - yvandenbroek - TriplyDB

Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation

Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation

http://www.wikidata.org/entity/Q35071289

about

Tumor stroma as targets for cancer therapy Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization.ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation Pericytes contribute to airway remodeling in a mouse model of chronic allergic asthma Pericytes, microvasular dysfunction, and chronic rejection.PTK7+ Mononuclear Cells Express VEGFR2 and Contribute to Vascular Stabilization by Upregulating Angiopoietin-1.Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration.Dynamics of airway blood vessels and lymphatics: lessons from development and inflammation Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis.Synergistic actions of blocking angiopoietin-2 and tumor necrosis factor-α in suppressing remodeling of blood vessels and lymphatics in airway inflammation Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo.Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus.Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation Diabetic wound regeneration using peptide-modified hydrogels to target re-epithelialization.Vascular disruption and the role of angiogenic proteins after spinal cord injury.Pericytes: a double-edged sword in cancer therapy.Lung Pericytes and Resident Fibroblasts: Busy Multitaskers.Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke Angiopoietins and Tie2 in vascular inflammation.Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling.Dynamic, heterogeneous endothelial Tie2 expression and capillary blood flow during microvascular remodeling Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis.Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1.ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling.Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.Intravital imaging-based analysis tools for vessel identification and assessment of concurrent dynamic vascular events.Tumor Microenvironment Targeted Nanotherapy

P2860

Q27015980-1C2B652C-30F3-4279-87C1-1BF243D8E725 Q28070234-2FF628D2-3462-4CD8-B21B-8D13C2ED6204 Q28078976-D4E46817-4C47-40E0-95FF-A3685A9AB6A3 Q30541878-1870D5B9-B8BF-4FBB-9625-0C26BF69CF3F Q33711943-803BF4EA-6F1C-4FD2-8A82-55C3DC8BE104 Q34345914-771E445B-6D7E-4501-B2FE-FAD4F2A63F47 Q34354002-F6F9416A-DDE6-4B2A-9DC1-0FAB6D17CA23 Q35126158-AEE388BA-72BC-4FC0-8F5E-41A005452708 Q35212821-05C69031-8B3D-49FD-9AC7-EE00CA3D5F0E Q35275345-06D98618-56CC-4A27-BEEA-9B1FBBA102AA Q35681643-F7F47863-292F-44B1-A517-A47702509A45 Q35789092-AC7A3DF0-0CE5-4B7F-A431-C24439478D9F Q35896048-96C28CD3-C4A1-4920-B01B-60F328104E07 Q35983848-0E807DB8-F57E-47AC-9D15-1C75BA1F883F Q36144944-E1176F02-0388-4024-B063-FE2BE0529875 Q36240638-74D2DDCE-D7C2-4C54-A096-AEE298C58095 Q36445579-68EEECF1-5BE3-4D47-95D9-3BBECA01450E Q37142182-38215BE9-F86C-4C65-972E-4388A19DFF3A Q37217491-91072494-E013-4160-9FC1-0CB529EE6C94 Q37323019-F8078483-E204-42B9-9385-6455EA67AFDE Q37997013-92A8C404-02BD-45A4-99B8-FF73C71E6DA0 Q38241791-DFAE451E-B137-4647-9034-C27AA6254349 Q38935618-C631660A-DD1E-4CBD-8D10-6424DE7F59CB Q39040401-E35DF580-7C03-4275-A1F4-228D18E04AFB Q39352145-446A28EB-2BB5-4F4D-A473-FB5554488403 Q40303500-9803EA0E-049B-444A-87F5-8C6A08169AB7 Q41490834-77022C2E-16BE-4E4A-841F-CB1B2A9D68F0 Q41667192-AB5B7D50-63B7-4A63-AC83-81DE57E589D0 Q44205350-8E8732DC-51AF-4F54-AC86-949507F80D98 Q46670121-85749538-2004-49CE-92A3-B62FC15F81EF Q53413992-1C005F36-5813-4528-AF29-3C160C4F8708 Q55713186-E9F48FA7-87DD-4A66-B612-1E17469EAEE3 Q59133567-D6A9775F-8ECB-4A4C-B2D6-5DC02C94BD9E

P2860

Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation

http://www.wikidata.org/entity/Q35071289

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pericyte requirement for anti- ...... ling in sustained inflammation

@ast

Pericyte requirement for anti- ...... ling in sustained inflammation

@en

type

label

Pericyte requirement for anti- ...... ling in sustained inflammation

@ast

Pericyte requirement for anti- ...... ling in sustained inflammation

@en

prefLabel

Pericyte requirement for anti- ...... ling in sustained inflammation

@ast

Pericyte requirement for anti- ...... ling in sustained inflammation

@en

P1433

Q35071289-A3A0705A-7979-4184-8AFA-17C624AE854C

P1476

Q35071289-DA3C37A9-E0A8-41C7-9347-2438F772BC98

P2093

Q35071289-09A66609-1DC0-4871-B9D7-BFF5A23B2259

Q35071289-10088C7F-80F3-46E1-85FD-B907C14DBBF8

Q35071289-1EF722A4-683E-4FC6-9879-EC18DFC0AB4A

Q35071289-21AD22F4-9A6C-4773-AC39-77D125693092

Q35071289-2C99069D-B4C8-4A6C-B9EF-E038A55A28F9

Q35071289-454117D8-BDFF-4FC9-8D17-D9ADC47FED8F

Q35071289-463143FD-936A-4038-BFDE-BCC944890F1A

Q35071289-50070F03-D702-4C8C-9E51-266A15DC741F

Q35071289-9A10D7A6-B98E-44B1-A484-D3CE1631E470

Q35071289-AB66AE00-6F36-4401-92D3-5CA513937CAE

P2860

Q35071289-054F9D6F-655F-4ACF-8C69-E2112DEDD3BC

Q35071289-07D589FC-A534-4543-9596-F44B0F03B23D

Q35071289-0CEAB2E1-A967-46A1-9BDD-D27E91BE0D59

Q35071289-0F79E76C-2B3C-4116-A390-B12F0349D098

Q35071289-11051955-9084-484C-A8CD-1367582970FB

Q35071289-1FA040AD-552B-4ECF-A157-B1B2F0538043

Q35071289-26BA68DF-C40B-47D1-A454-0046ACA078BB

Q35071289-29B40E5A-2A55-4F80-916B-DB0DC92F38DE

Q35071289-2AC5C6E4-459B-4A37-A2F2-61EDA7C25532

Q35071289-2FB7ED2E-26A8-44CF-8B9E-FC8222C1D295

P304

Q35071289-D8D0280E-7A23-44D8-9458-50DFB88B0B19

P31

Q35071289-215AF672-9657-4BFB-B76B-C333A45B67C1

P356

Q35071289-A46942F7-FA8E-4953-A385-21C1611D9590

P407

Q35071289-CBC8CD07-F7E4-44D5-AD17-BA37379DF64B

P433

Q35071289-15914140-19E6-47A3-8DD5-10CC7B78FDAB

P478

Q35071289-C9BF8FFF-871E-44AF-9016-60118BC5E177

P50

Q35071289-4396C489-E735-49F4-B759-FBADBB8A6064

P577

Q35071289-3BC57DEE-98C5-4702-88DC-CC65FA9BFCF4

P5875

Q35071289-BBAD4F14-EBA4-4E1C-ACFF-4DF2C444F1C2

P698

Q35071289-D2C32B23-9D9F-4E5D-8730-A2B66C0FFDD0

P921

Q35071289-35F53C89-5CB3-482D-AD76-6F972BFABD9C

P932

Q35071289-578005E7-E44A-448A-B981-A106CDBA159E

P356

J.AJPATH.2011.02.008

P1433

The American Journal of Pathology

P1476

Pericyte requirement for anti- ...... ling in sustained inflammation

@en

P2093

Alicia Adams

http://www.w3.org/2001/XMLSchema#string

David M Epstein

http://www.w3.org/2001/XMLSchema#string

Donald M McDonald

http://www.w3.org/2001/XMLSchema#string

Erin Lashnits

http://www.w3.org/2001/XMLSchema#string

Gou Young Koh

http://www.w3.org/2001/XMLSchema#string

Harras Zaid

http://www.w3.org/2001/XMLSchema#string

Katharine Colton

http://www.w3.org/2001/XMLSchema#string

Peter Baluk

http://www.w3.org/2001/XMLSchema#string

Shaun O'Brien

http://www.w3.org/2001/XMLSchema#string

Sébastien Tabruyn

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts

Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function

Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation

Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo

P304

2897-2909

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2011.02.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51105429

http://www.w3.org/2001/XMLSchema#string

P698

21550017

http://www.w3.org/2001/XMLSchema#string

P921

P932

3124300

http://www.w3.org/2001/XMLSchema#string